These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38256412)

  • 41. Understanding the patient experience and treatment benefits in patients with non-small-cell lung cancer with brain metastasis.
    Cella D; Wen PY; Ervin C; Vallow S; Gilloteau I; DeMuro C; Mordin M; Chassot Agostinho A; Dine J
    Cancer Med; 2023 Jun; 12(12):13637-13648. PubMed ID: 37306665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
    Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L
    Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression.
    Wakuda K; Yabe M; Kodama H; Nishioka N; Miyawaki T; Miyawaki E; Mamesaya N; Kawamura T; Kobayashi H; Omori S; Ono A; Kenmotsu H; Naito T; Murakami H; Harada H; Endo M; Gon Y; Takahashi T
    Lung Cancer; 2021 Jan; 151():60-68. PubMed ID: 33246646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strategies to prevent brain metastasis in high-risk non-small-cell lung cancer: lessons learned from a randomized study of maintenance temozolomide versus observation.
    Boggs DH; Robins HI; Langer CJ; Traynor AM; Berkowitz MJ; Mehta MP
    Clin Lung Cancer; 2014 Nov; 15(6):433-40. PubMed ID: 25069747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of adenylate cyclase-associated protein 1 may predict brain metastasis in non-small cell lung cancer.
    Xie SS; Tan M; Lin HY; Xu L; Shen CX; Yuan Q; Song XL; Wang CH
    Oncol Rep; 2015 Jan; 33(1):363-71. PubMed ID: 25371324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.
    Seesaghur A; Egger P; Warden J; Abbasi A; Levick B; Riaz M; McMahon P; Thompson M; Cheeseman S
    BMJ Open; 2023 May; 13(5):e069214. PubMed ID: 37156580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Economic burden in patients with ALK + non-small cell lung cancer, with or without brain metastases, receiving second-line anaplastic lymphoma kinase (ALK) inhibitors.
    Lin HM; Pan X; Hou P; Huang H; Wu Y; Ren K; Jahanzeb M
    J Med Econ; 2020 Aug; 23(8):894-901. PubMed ID: 32347754
    [No Abstract]   [Full Text] [Related]  

  • 48. Front-line therapy for brain metastases and non-brain metastases in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: a network meta-analysis.
    Zhu Y; Liu C; Xu Z; Zou Z; Xie T; Xing P; Wang L; Li J
    Chin Med J (Engl); 2023 Nov; 136(21):2551-2561. PubMed ID: 37160733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence Analysis.
    O'Kane GM; Su J; Tse BC; Tam V; Tse T; Lu L; Borean M; Tam E; Labbé C; Naik H; Mittmann N; Doherty MK; Bradbury PA; Leighl NB; Shepherd FA; Richard NM; Edelstein K; Shultz D; Brown MC; Xu W; Howell D; Liu G
    Oncologist; 2019 Jul; 24(7):e501-e509. PubMed ID: 30952820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EGFR mutation status and its impact on survival of Chinese non-small cell lung cancer patients with brain metastases.
    Luo D; Ye X; Hu Z; Peng K; Song Y; Yin X; Zhu G; Ji Q; Peng Y
    Tumour Biol; 2014 Mar; 35(3):2437-44. PubMed ID: 24197981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis.
    Byeon S; Ham JS; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Med Oncol; 2016 Aug; 33(8):97. PubMed ID: 27447711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer.
    da Silva GT; Bergmann A; Thuler LCS
    Support Care Cancer; 2016 Feb; 24(2):731-736. PubMed ID: 26143039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long noncoding RNA LGALS8-AS1 promotes angiogenesis and brain metastases in non-small cell lung cancer.
    Zhong J; Wang B
    Acta Biochim Pol; 2023 Sep; 70(3):551-559. PubMed ID: 37716002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.
    Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin.
    Bosch-Barrera J; Sais E; Cañete N; Marruecos J; Cuyàs E; Izquierdo A; Porta R; Haro M; Brunet J; Pedraza S; Menendez JA
    Oncotarget; 2016 May; 7(22):32006-14. PubMed ID: 26959886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive value of serum bone sialoprotein in patients with bone metastasis of non-small cell lung cancer.
    He JJ; Zhi K; Liu GF
    Onkologie; 2011; 34(11):584-8. PubMed ID: 22104154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer.
    Yang XR; Pi C; Yu R; Fan XJ; Peng XX; Zhang XC; Chen ZH; Wu X; Shao Y; Wu YL; Zhou Q
    Clin Exp Metastasis; 2021 Feb; 38(1):109-117. PubMed ID: 33231826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of single-nucleotide polymorphisms in the mTORC1 pathway on the risk of brain metastasis in patients with non-small cell lung cancer.
    Xu Y; Huang Y; Weng L; Zheng J; Huang Y; Lin Y; Zhao Y; Li H; Chen Y
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):273-285. PubMed ID: 31641854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer.
    Ortuzar W; Hanna N; Pennella E; Peng G; Langer C; Monberg M; Scagliotti G
    Clin Lung Cancer; 2012 Jan; 13(1):24-30. PubMed ID: 21831719
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spine-specific skeletal related events and mortality in non-small cell lung cancer patients: a single-institution analysis.
    Adogwa O; Rubio DR; Buchowski JM; D'Souza A; Shlykov MA; Jennings JW
    J Neurosurg Spine; 2022 Jan; 36(1):125-132. PubMed ID: 33254136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.